Periodical information
三才期刊采编系统
Acquisition System
（1993年创刊  月刊）
Sponsors
Chinese Anti-cancer Association
Shaanxi Anti-cancer Association of China
Shaanxi Cancer Institute 
Editing & Publishing
Editorial Board of Journal of Modern Oncology
309 Yanta West Road Xi＇an Shaanxi Province 710061, P.R.China
Tel：0086-029-85578876
0086-029-85277356
0086-029-85276012
Fax:0086-029-85277356
http://www.xdzlyx.com/
E-mail：sxzlyx@263.net
Chief of Magazine Agency
Geng Qingyi(耿庆义)
Editor-in-Chief & Managing Director
Li Shuye(李树业)
Honorary editor in chief
Fan Daiming(樊代明)
Hao Xishan(郝希山)
Subscriptions
Domestic
Local Post Offices,China Post subscription code 52-297
Overseas
China International Book Trading Corporation
P.O.Box 399,Beijing 100044,China. Code No：M1985
Licence for Advertising
Shaanxi Industrial Commer-cial:6100004000094
Printing
Printing Branch of Xi＇an Haoxuan printing Co.Ltd 
CSSN
ISSN 1672-4992
CN 61-1415/R
Price
RMB ￥15.00
US $6.00
Journal introduction
  
   “Modern Oncology”(ISSN1672-4992,CN61-1415/R, monthly) is a national professional academic journal of oncology approved by the Ministry of Science and Technology and the Press and Publication Administration for public distribution at home and abroad, and a series of journals of China Anti-Cancer Association. This journal is the Statistical Source Journal of Chinese Science and Technology Papers of the Ministry of Science and Technology of China (China Science and Technology Core Journals)(2004-2024), “Overview of Chinese Core Journals”(9th Edition), “Chemical Abstracts of USA”, ”Japan Science and Technology Agency Database (JST China)”, World Journal Clout Index (WJCI) Report of Scientific and Technological Periodicals, RCCSE China Core Academic Journals (A), “China Journals Network”, “Chinese Academic Journal (CD-ROM Version) Full Text Database”, “China Core Journals (Selection) Database”, "Chinese Biomedical Literature Database" and "China Science and Technology Journal Database" "Annual Report for Chinese Academic Journals Impact Factors", "Comprehensive Evaluation Database of Chinese Academic Journals", "Wanfang Data-Digital Periodical (WANGFANF DATA)", Full-text Online Periodicals on Superstar Journal Domain Publishing Platform, and "CAJ-CD Norms" Executive Excellent Periodicals. The journal mainly introduces the latest achievements in the field of oncology and the new progress and new trends of tumor diagnosis and treatment technology at home and abroad, and publishes the basic research on tumor, achievements of clinical diagnosis and treatment of oncology, as well as innovative, scientific new methods, new inventions and new experiences, and strives to serve the academic exchange and discipline development of oncology. The main columns include monograph, original article, basic research, clinical research, review, epidemiology, short report, exchange of experience, integration of traditional Chinese and western medicine, and so on.
Current Issue: 2025,Vol.33,NO.04
[525-547] Research progress of immunotherapy for lung cancer
[ZHANG Xu,CAO Wanxin,LI Xiaoxue,YANG Hong,LI Wan,CHI Xiangyin,DU Guanhua,WANG Jinhua]
2025 04 [Abstract]()
[548-556] Folate deficiency inhibits colorectal cancer HCT-116 cell migration through the miR-5002-5p-Gadd45α axis
[CAO Yu1,2,LU Lin3,ZHU Yuqian1,4,GUO Xihan1,WANG Han1,WANG Xu1,5,NI Juan1]
2025 04 [Abstract]()
[557-566] Combining bulk and single-cell sequencing data to develop a prognostic model of immunogenic cell death in hepatocellular carcinoma based on machine learning
[DU Yanan，WANG Yixuan，XIE Li，LI Rutian]
2025 04 [Abstract]()
[567-575] Exploring the molecular mechanisms underlying Nobiletin’ s inhibition of osteosarcoma growth based on multi-method
[LI Xiangping，YAN-ZHANG Ruoping，YANG Zhaojie，ZHANG Yongyong，CHEN Qian]
2025 04 [Abstract]()
[576-582] miR-29a-3p inhibits cisplatin resistance of osteosarcoma cells by targeting TRAF5
[KUANG Jian1，DONG Wengang2，DING Jiayun1，XIE Qing1，LIU Wenyi1，ZHOU Zhijian1，LIU Jun1]
2025 04 [Abstract]()
[583-589] Norcantharidin inhibits the proliferation of small cell lung cancer H446 cells via Nrf2/HO-1 pathway mediated ferroptosis
[SU Fan,LIU Dan,DENG Shukai]
2025 04 [Abstract]()
[590-597] Dosimetry study based on tangential arc radiotherapy at the medial margin of mammary gland after radical resection of left breast cancer
[LI Han，ZHAO Biao,YUAN Meifang，LI Jing，ZHU Cencheng,YANG Yi]
2025 04 [Abstract]()
[598-606] Dosimetric comparison of different radiotherapy techniques in whole breast irradiation after breast-conserving surgery for left breast cancer
[NING Jing,ZHAO Zhipeng,GUO Xin,WU Ning]
2025 04 [Abstract]()
[607-613] The diagnostic value of S-Detect technology combined with clinical characteristics based on BI-RADS classification for benign and malignant breast masses
[LI Wenxiao，ZHANG Yurui，LIU Wen，YAN Xiaojun，SHI Linan，CAO Chunli，WANG Sirui，LI Jun，CHENG Jing]
2025 04 [Abstract]()
[614-619] Expression and clinical significance of integrin linked kinase ILK in BRAF mutant thyroid cancer
[YANG Mengmeng,CHEN Hongyue,WANG Xinyu]
2025 04 [Abstract]()
[620-627] Diagnostic value of deep learning model based on CT images for adjacent tumor deposits in colorectal cancer
[LIU Yan,LUO Jinwen,LIU Yanli,TANG Yaxia]
2025 04 [Abstract]()
[628-635] Efficacy and safety of sindilizumab combined with chemotherapy in neoadjuvant treatment of locally progressive gastric cancer
[DENG Zhongquan1,CHEN Dezhen1,ZHU Haiqiang1,WU Jiaming2]
2025 04 [Abstract]()
[636-640] Calculation of the association between tumor clinical efficacy and long-term health benefits:A case study of a blood tumor
[LIU Chang1,TAO Libo1,2,WU Yao1,WANG Fangxu1,YAN Yi1,SUN Shuang1]
2025 04 [Abstract]()
[641-647] Relationship between cardiometabolic index and neutrophil/lymphocyte ratio and prognosis of patients with colorectal cancer
[REN Xuekang,ZHU Shaogong,XIA Yunzhan]
2025 04 [Abstract]()
[648-652] Clinical and pathological characteristics analysis of Hobnail variant of papillary thyroid carcinoma (25 cases)
[TAN Zhihui,JIA Hao,TANG Xuefeng]
2025 04 [Abstract]()
[653-659] Retrospective analysis of anesthesia management in patients with renal cell carcinoma complicated with tumor thrombus in inferior vena cava
[WANG Yi1,ZHU Zheng2,WANG Yonghui1,FU Jingwen1,ZHU Zhenghua1,LU Zhihong1,FAN Qianqian1]
2025 04 [Abstract]()
[669-675] Advances in preclinical model of cervical cancer
[CHEN Yuanjing1,LIU Xiaofeng1,LI Wen2,LUO Renjie1,WANG Dan1,ZHANG Wenyan1,LIU Huiling2]
2025 04 [Abstract]()
[676-682] Advancements in the application of laparoscopic technology in the field of gallbladder cancer
[ZHENG Kai，JIANG Gaiming，LI Jing，KANG Qiang，KE Yang，LI Yuehua]
2025 04 [Abstract]()
[683-689] The biological function of PDCD10 gene and its research progress in tumor
[DING Peng,CHEN Xu,LIU Sulai,SUN Bo]
2025 04 [Abstract]()
[690-694] Research progress of ovarian small cell neuroendocrine carcinoma
[WEI Jia1，GUO Xi1，LIU Simin1，WANG Jiali1，ZHENG Duo2,LI Hongli2，YANG Yongxiu2]
2025 04 [Abstract]()
[695-700] Research progress on the role of ferritin light chains in promoting the migration,invasion,and drug resistance of glioma cells
[SUN Yabo，ZHU Yongji，YU Jianglong]
2025 04 [Abstract]()
[701-711] Research progress of CT radiomics in spatiotemporal heterogeneity of gastric cancer
[ZHONG Xiaoyu1,WANG Yueling1,2,LIU Jiarang1,FAN Jiaqi1,XU Tian1,HE Siyi1,HUANG Benhao1,HUANG Chen1]
2025 04 [Abstract]()
[712-718] Research progress of tumor-infiltrating lymphocytes(TILs) immunotherapy and its application in lung cancer treatment
[GONG Xinyu，LI Qiang，LI Chuan，WEI Jiayao，YANG Zefeng，FAN Yujie]
2025 04 [Abstract]()